Bordetella bronchiseptica fimbrial protein-enhanced immunogenicity of a Mannheimia haemolytica leukotoxin fragment

By Rajeev S.   Kania S.A.   Nair R.V.   McPherson J.T.   Moore R.N.   Bemis D.A.  

Vaccine, Vol. 19, Iss. 32, 2001-09 ,pp. : 4842-4850

Elsevier

Access to resources Recommend Favorite

Use of a rationally attenuated Bordetella bronchiseptica as a live mucosal vaccine and vector for heterologous antigens

By Stevenson A.   Roberts M.  

Vaccine, Vol. 20, Iss. 17, 2002-05 ,pp. : 2325-2335

Elsevier

Access to resources Recommend Favorite

Characterization of Newcastle disease virus vaccines by biological properties and sequence analysis of the hemagglutinin-neuraminidase protein gene

By Seal B.S.   King D.J.   Bennett J.D.  

Vaccine, Vol. 14, Iss. 8, 1996-06 ,pp. : 761-766

Elsevier

Access to resources Recommend Favorite

Stimulation of mucosal and systemic antibody responses against Bordetella pertussis filamentous haemagglutinin and recombinant pertussis toxin after nasal administration with chitosan in mice

By Jabbal-Gill I.   Fisher A.N.   Rappuoli R.   Davis S.S.   Illum L.  

Vaccine, Vol. 16, Iss. 20, 1998-12 ,pp. : 2039-2046

Elsevier

Access to resources Recommend Favorite

Immune responses and protection against Bordetella pertussis infection after intranasal immunization of mice with filamentous haemagglutinin in solution or incorporated in biodegradable microparticles

By Cahill E.S.   O'Hagan D.T.   Illum L.   Barnard A.   Mills K.H.G.   Redhead K.  

Vaccine, Vol. 13, Iss. 5, 1995-01 ,pp. : 455-462

Elsevier

Access to resources Recommend Favorite